Evidence map›Paper›PMID 33017416›Full record

ArticlePLoS neglected tropical diseases2020

Proteomic analysis of plasma exosomes from Cystic Echinococcosis patients provides in vivo support for distinct immune response profiles in active vs inactive infection and suggests potential biomarkers.

Federica Fratini, F Tamarozzi, G Macchia, L Bertuccini, M Mariconti, C Birago, A Iriarte, E Brunetti, C M Cretu, O Akhan and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Improvement of small extracellular vesicle isolation from mouse model blood.Extracellular vesicles and circulating nucleic acids · 2025
    Article
  5. Article
  6. Article
  7. Cystic Echinococcosis in the Early 2020s: A Review.Tropical medicine and infectious disease · 2024
    Review
  8. Progresses and challenges inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Characterization of the B-Cell Epitopes ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 5 countries.

Federica FratiniProteomics Core Facility, Istituto Superiore di Sanità(ISS), Rome, Italy.ORCID 0000-0003-0807-930X
F TamarozziWho Collaborating Centre for Epidemiology, Detection and Control of Cystic and Alveolar Echinococcosis, Department of Infectious, Diseases (DMI), ISS, Rome, Italy.
G MacchiaProteomics Core Facility, Istituto Superiore di Sanità(ISS), Rome, Italy.
L BertucciniElectron Microscopy Core Facility, ISS, Rome, Italy.ORCID 0000-0002-4278-2376
M MaricontiDepartment of Clinical Surgical Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0003-4154-930X
C BiragoDepartment of Infectious, Diseases (DMI), ISS, Rome, Italy.
A IriarteLaboratorio de Biología Computacional, Dpto. de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.ORCID 0000-0002-5862-0152
E BrunettiDepartment of Clinical Surgical Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.
C M CretuUniversity of Medicine and Pharmacy, Colentina Clinical Hospital-Parasitology, Bucharest, Romania.
O AkhanFaculty of Medicine, Hacettepe University, Ankara, Turkey.
M Siles-LucasInstituto de Recursos Naturales y Agrobiologı´a de Salamanca (IRNASA-CSIC), Salamanca, Spain.
A DíazÁrea Inmunología, Departamento de Biociencias, Facultad de Química, Universidad de la República, Montevideo, Uruguay.ORCID 0000-0001-5375-6766
Adriano CasulliWho Collaborating Centre for Epidemiology, Detection and Control of Cystic and Alveolar Echinococcosis, Department of Infectious, Diseases (DMI), ISS, Rome, Italy.
Istituto Superiore di Sanità · ITUniversidad de la República de Uruguay · UYUniversity of Pavia · ITEuropean Hospital · ITHacettepe University · TRInstituto de Recursos Naturales y Agrobiología de Salamanca · ESSpitalul Clinic Colentina · ROWorld Health Organization - Italy · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reference diagnostic method of human abdominal Cystic Echinococcosis (CE) is imaging, particularly ultrasound, supported by serology when imaging is inconclusive. However, current diagnostic tools are neither optimal nor widely available. The availability of a test detecting circulating biomarkers would considerably improve CE diagnosis and cyst staging (active vs inactive), as well as treatments and follow-up of patients. Exosomes are extracellular vesicles involved in intercellular communication, including immune system responses, and are a recognized source of biomarkers. With the aim of identifying potential biomarkers, plasma pools from patients infected by active or inactive CE, as well as from control subjects, were processed to isolate exosomes for proteomic label-free quantitative analysis. Results were statistically processed and subjected to bioinformatics analysis to define distinct features associated with parasite viability. First, a few parasite proteins were identified that were specifically associated with either active or inactive CE, which represent potential biomarkers to be validated in further studies. Second, numerous identified proteins of human origin were common to active and inactive CE, confirming an overlap of several immune response pathways. However, a subset of human proteins specific to either active or inactive CE, and central in the respective protein-protein interaction networks, were identified. These include the Src family kinases Src and Lyn, and the immune-suppressive cytokine TGF-β in active CE, and Cdc42 in inactive CE. The Src and Lyn Kinases were confirmed as potential markers of active CE in totally independent plasma pools. In addition, insights were obtained on immune response profiles: largely consistent with previous evidence, our observations hint to a Th1/Th2/regulatory immune environment in patients with active CE and a Th1/inflammatory environment with a component of the wound healing response in the presence of inactive CE. Of note, our results were obtained for the first time from the analysis of samples obtained in vivo from a well-characterized, large cohort of human subjects.

Indexed as

AdultAnimalsBiomarkersCytokinesEchinococcosisEchinococcus granulosusExosomesFemaleHumansMaleMass SpectrometryPlasmaProteomicsBiomarkersCytokines

Identifiers

PMID33017416
PMCPMC7535053
OpenAlexW3091345426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.